Forte Biosciences Inc (FBRX)

CUSIP: 34962G208 | NYSE | Healthcare · Biotechnology | Small Cap | 126 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13G/ATybourne Kesari Ltd	0	0.0%	No shares held	Sep 30, 2026	No 13F filer matched
13G/AFederated Hermes, Inc.	0	0.0%	Fell below 5%	Aug 31, 2026

Institutional Holders — Q3 2026

Sort by

IFP Advisors, Inc3

0.0% of portfolio$231

				Style	Turnover	Location	Filed
IFP Advisors, Inc	3	$231	0.0%	Growth	Low	Tampa, FL	2026-10-16

13G/ATybourne Kesari Ltd0

0.0% of class · Sep 30, 2026No shares held

No 13F filer matched

13G/AFederated Hermes, Inc.0

0.0% of class · Aug 31, 2026Fell below 5%

No 13F filer matched

13G Glazer Capital, LLC300,000

1.5% of class · Aug 4, 2026Newly reported

Not yet in a 13F

13G/AAlger Associates, Inc.935,514

4.6% of class · Jul 31, 2026Newly reported

No 13F filer matched

13G/A Henderson Group PLC521,016

2.5% of class · Jul 31, 2026−1,373,060

122d ahead of 13F (1,188,060 sh) · −667,044

13G/AOrbimed Advisors LLC1,264,980

6.2% of class · Jun 30, 2026New 5%+ stake

with OrbiMed Capital GP IX LLC, Orbimed Capital LLC

No 13F filer matched

13G/AAffinity Asset Advisors, LLC1,145,391

5.6% of class · Jun 30, 2026New 5%+ stake

No 13F filer matched

13G/AAdage Capital Management, L.P.700,000

3.4% of class · Jun 30, 2026Newly reported

No 13F filer matched

13G/AMillennium Management LLC655,199

3.2% of class · Jun 30, 2026Newly reported

No 13F filer matched